首页> 美国卫生研究院文献>Frontiers in Public Health >Bigger and Better? Representativeness of the Influenza A Surveillance Using One Consolidated Clinical Microbiology Laboratory Data Set as Compared to the Belgian Sentinel Network of Laboratories
【2h】

Bigger and Better? Representativeness of the Influenza A Surveillance Using One Consolidated Clinical Microbiology Laboratory Data Set as Compared to the Belgian Sentinel Network of Laboratories

机译:更大更好?与比利时前哨实验室网络相比使用一个综合临床微生物学实验室数据集的甲型流感监测的代表性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Infectious diseases remain a serious public health concern globally, while the need for reliable and representative surveillance systems remains as acute as ever. The public health surveillance of infectious diseases uses reported positive results from sentinel clinical laboratories or laboratory networks, to survey the presence of specific microbial agents known to constitute a threat to public health in a given population. This monitoring activity is commonly based on a representative fraction of the microbiology laboratories nationally reporting to a single central reference point. However, in recent years a number of clinical microbiology laboratories (CML) have undergone a process of consolidation involving a shift toward laboratory amalgamation and closer real-time informational linkage. This report aims to investigate whether such merging activities might have a potential impact on infectious diseases surveillance. Influenza data was used from Belgian public health surveillance 2014–2017, to evaluate whether national infection trends could be estimated equally as effectively from only just one centralized CML serving the wider Brussels area (LHUB-ULB). The overall comparison reveals that there is a close correlation and representativeness of the LHUB-ULB data to the national and international data for the same time periods, both on epidemiological and molecular grounds. Notably, the effectiveness of the LHUB-ULB surveillance remains partially subject to local regional variations. A subset of the Influenza samples had their whole genome sequenced so that the observed epidemiological trends could be correlated to molecular observations from the same period, as an added-value proposition. These results illustrate that the real-time integration of high-throughput whole genome sequencing platforms available in consolidated CMLs into the public health surveillance system is not only credible but also advantageous to use for future surveillance and prediction purposes. This can be most effective when implemented for automatic detection systems that might include multiple layers of information and timely implementation of control strategies.
机译:传染病在全球仍然是严重的公共卫生问题,而对可靠和有代表性的监视系统的需求仍然与以往一样迫切。传染病的公共卫生监督使用前哨临床实验室或实验室网络报告的阳性结果,调查已知微生物对特定人群构成威胁的特定微生物制剂的存在。这种监测活动通常基于全国报告给单个中央参考点的微生物实验室的代表性部分。但是,近年来,许多临床微生物学实验室(CML)经历了整合过程,涉及向实验室合并和更紧密的实时信息链接的转变。本报告旨在调查此类合并活动是否可能对传染病监视产生潜在影响。比利时2014-2017年公共卫生监测中使用了流感数据,以评估仅通过一个服务于整个布鲁塞尔地区的集中式CML(LHUB-ULB)是否可以同样有效地估计全国感染趋势。总体比较表明,从流行病学和分子学角度来看,LHUB-ULB数据与同一时期的国家和国际数据具有密切的相关性和代表性。值得注意的是,LHUB-ULB监视的有效性仍然部分受当地区域差异的影响。一部分流感样本的整个基因组都经过了测序,因此观察到的流行病学趋势可以与同一时期的分子观察结果相关联,以此作为增值主张。这些结果说明,将整合的CML中可用的高通量全基因组测序平台实时整合到公共健康监测系统中不仅可信,而且有利于将来的监测和预测。当对可能包含多层信息并及时实施控制策略的自动检测系统实施时,这可能是最有效的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号